Can Nike Outrun a Ban on Its Latest Shoes?

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Can Nike Outrun a Ban on Its Latest Shoes?

© ZamoraA / Getty Images

Nike Inc. (NYSE: NKE | NKE Price Prediction) has made great strides over the past year, not only with its shares up incredibly but also its new Vaporfly Next% shoes have dominated the running scene.

However, there are concerns that World Athletics (formerly the International Association of Athletic Federations) will ban the shoes from competition. This comes as allegations that the shoe’s unique design provides an unfair advantage to runners.

Vaporfly has come under scrutiny amid claims that its foam and carbon fiber composition in the sole acts as a spring that gives runners an edge by providing an increased forward push on each stride.

Separately, there are concerns that the long-term health risks of the shoe’s design and the impact that it might have on runners who primarily use their heels rather than toes as springboards in their strides.

On the other hand (or foot), this shoe was worn by Kenya’s Brigid Kosgei when she set the record for the fastest marathon time for a woman, winning the women’s event of the Chicago Marathon this last October. Also, this shoe helped propel Kenyan running champion Eliud Kipchoge when he was the first-ever athlete to break the two-hour mark for a marathon, which was once thought impossible.

[nativounit]

As a result of this potential ban, over-the-counter shares of rival shoe company Asics saw a bump on Thursday. Japanese shoemaker Mizuno saw a small gain as well. Although some might call this a hollow victory, as news of the ban will only bring more attention to Nike’s shoe line.

Excluding Thursday’s move, Nike stock had outperformed the broad markets with about 32% gain in the past 52 weeks. In the past quarter, though, the stock was up only 8%.

Shares of Nike were last seen up about 0.5% at $103.35, in a 52-week range of $77.07 to $103.89. The consensus price target is $109.78.

Asics traded up about 4% to $15.89 a share. The 52-week range is $10.55 to $17.83, and over the past 52 weeks the stock is up 14%.

[recirclink id=636357]
[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618